Literature DB >> 32305337

Profiling calcium-dependent interactions between Sorcin and intrinsically disordered regions of human proteome.

Ilaria Genovese1, Andrea Carotti2, Andrea Ilari3, Annarita Fiorillo4, Theo Battista4, Gianni Colotti3, Ylva Ivarsson5.   

Abstract

BACKGROUND: Sorcin is a calcium sensor that exerts many calcium-related functions in the cells, e.g. it regulates calcium concentration in the cytoplasm, endoplasmic reticulum (ER) and mitochondria, by interacting with calcium pumps, exchangers and channels. Albeit Sorcin is an interesting potential cancer target, little is known about its interactors upon calcium-mediated activation. Our previous study suggested that Sorcin may recognize short linear binding motifs as the crystal structure revealed a self-interaction with a GYYPGG stretch in its N-terminus, and combinatorial peptide-phage display provided support for peptide-mediated interactions.
METHODS: In this study we screened for motif-based interactions between Sorcin and intrinsically disordered regions of the human proteome using proteomic peptide phage display (ProP-PD). We identified a peptide belonging to protein phosphatase 1 regulatory subunit 3G (PPP1R3G) as a potential novel interactor and confirm the interaction through biophysical and cell-based approaches, and provide structural information through molecular dynamics simulations.
RESULTS: Altogether, we identify a preferred motif in the enriched pool of binders and a peptide belonging to protein phosphatase 1 regulatory subunit 3G (PPP1R3G) as a preferred ligand.
CONCLUSION: Through this study we gain information on a new Sorcin binding partner and profile Sorcin's motif-based interaction. GENERAL SIGNIFICANCE: The interaction between Sorcin and PPP1R3G may suggest a close dependence between glucose homeostasis and calcium concentration in the different cell compartments, opening a completely new and interesting scenery yet to be fully disclosed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Protein-protein interaction; Proteomic peptide phage display (ProP-PD); Short linear motif; Sorcin

Mesh:

Substances:

Year:  2020        PMID: 32305337     DOI: 10.1016/j.bbagen.2020.129618

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  4 in total

1.  Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis.

Authors:  Chenglong Wang; Xiaolin Xu; Peipei Zhang; Shuhan Xiong; Jia Yuan; Xuzhu Gao; Wencai Guan; Fanchen Wang; Xin Li; Hongjing Dou; Guoxiong Xu
Journal:  J Nanobiotechnology       Date:  2022-07-07       Impact factor: 9.429

2.  Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.

Authors:  Ilaria Genovese; Flavia Giamogante; Lucia Barazzuol; Theo Battista; Annarita Fiorillo; Mattia Vicario; Giuseppina D'Alessandro; Raffaela Cipriani; Cristina Limatola; Daniela Rossi; Vincenzo Sorrentino; Elena Poser; Luciana Mosca; Ferdinando Squitieri; Marzia Perluigi; Andrea Arena; Filip van Petegem; Claudia Tito; Francesco Fazi; Carlotta Giorgi; Tito Calì; Andrea Ilari; Gianni Colotti
Journal:  Cell Death Dis       Date:  2020-10-15       Impact factor: 8.469

3.  AnnexinA7 promotes epithelial-mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma.

Authors:  Fei Ling; Huan Zhang; Yunliang Sun; Jinyi Meng; Jaceline Gislaine Pires Sanches; He Huang; Qingqing Zhang; Xiao Yu; Bo Wang; Li Hou; Jun Zhang
Journal:  Cell Death Dis       Date:  2021-10-29       Impact factor: 8.469

4.  Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.

Authors:  Xingli Zhuo; Lan Chen; Zongwei Lai; Jiansheng Liu; Shengjun Li; Ahu Hu; Yuansheng Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.